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Abstract
Background: MicroRNAs (miRNAs) are small non-coding RNAs that can exert multilevel inhibition/repression at a
post-transcriptional or protein synthesis level during disease or development. Characterisation of miRNAs in adult
mammalian brains by deep sequencing has been reported previously. However, to date, no small RNA profiling of
the developing brain has been undertaken using this method. We have performed deep sequencing and small
RNA analysis of a developing (E15.5) mouse brain.
Results: We identified the expression of 294 known miRNAs in the E15.5 developing mouse brain, which were
mostly represented by let-7 family and other brain-specific miRNAs such as miR-9 and miR-124. We also discovered
4 putative 22-23 nt miRNAs: mm_br_e15_1181, mm_br_e15_279920, mm_br_e15_96719 and mm_br_e15_294354
each with a 70-76 nt predicted pre-miRNA. We validated the 4 putative miRNAs and further characterised one of
them, mm_br_e15_1181, throughout embryogenesis. Mm_br_e15_1181 biogenesis was Dicer1-dependent and was
expressed in E3.5 blastocysts and E7 whole embryos. Embryo-wide expression patterns were observed at E9.5 and
E11.5 followed by a near complete loss of expression by E13.5, with expression restricted to a specialised layer of
cells within the developing and early postnatal brain. Mm_br_e15_1181 was upregulated during
neurodifferentiation of P19 teratocarcinoma cells. This novel miRNA has been identified as miR-3099.
Conclusions: We have generated and analysed the first deep sequencing dataset of small RNA sequences of the
developing mouse brain. The analysis revealed a novel miRNA, miR-3099, with potential regulatory effects on early
embryogenesis, and involvement in neuronal cell differentiation/function in the brain during late embryonic and
early neonatal development.
Background
A class of small non-coding RNA (19-25 nt in length)
known as microRNA (miRNA) [1-3] can exert multilevel
inhibition/repression processes during post-transcrip-
tional or protein synthesis stages [4,5]. miRNAs are
transcribed in the nucleus into long polyadenylated
RNAs known as primary (pri)-miRNAs that contain
~60-90 nt secondary hairpin structures termed precur-
sor (pre)-miRNAs. The RNase III enzymes Rnasen and
Dgcr8 then excise the pre-miRNA from the pri-miRNA
[1,6-9]. The pre-miRNA hairpin is transported into the
cytoplasm via the nuclear transport receptor, Xpo5, and
further processed by another RNase III enzyme, Dicer,
into a small RNA duplex containing the functional
mature miRNA and a passenger strand known as
miRNA star [9-11]. The majority of the miRNA star are
non-functional and are rapidly degraded, but a small
proportion have conserved seed regions, potentially with
regulatory roles [12]. The mature miRNA forms a com-
ponent of the RNA-induced silencing complexes (miR-
ISC) and guides these complexes to mRNA targets via
sequence-specific pairing between the miRNA seed
sequence (the first 7 nt of the miRNA starting from
position 2) and the mRNA. Typically, miRNAs guide the
RISC complex to the target mRNA 3’ UTR, but inci-
dences where 5’ UTR and coding-sequences were tar-
geted have been reported [13-15]. In mammals, miRISC
normally effects translational repression and, depending
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tation, can direct mRNA degradation [5,16]. Another
intriguing regulatory role of miRNAs is the silencing of
gene transcription which has been observed in plants
[17], but has not yet been reported in the mammalian
system.
Mammalian brain development requires meticulous
spatio-temporal regulation of gene/protein expression,
from the transcription of DNA within the nucleus to
translation of mRNA in the cytoplasm [18,19]. At
embryonic day 15.5 (E15.5), the mouse brain undergoes
rapid cellular and anatomical changes involving neuro-
nal migration in the cerebral cortex, proliferation of
neural progenitor/stem cells at germinative zones, glio-
genesis, axonogenesis and rostro-lateral to caudo-medial
structure patterning [20-22]. MiRNAs play crucial roles
during brain development and function. MiR-134,f o r
example, is localised to the synapto-dendritic compart-
ment of rat hippocampal neurones and has been linked
to synaptic development, maturation and plasticity [23].
MiR-9 regulates the patterning activities and neurogen-
esis at the midbrain-hindbrain boundary in zebrafish
[24] and miR-124 triggers brain-specific alternative pre-
mRNA splicing leading to neuronal differentiation in
the mouse [25]. MiRNAs are also associated with neuro-
logical disorders such as schizophrenia [26] and Hun-
tington’s disease [27]. To date, there are only 672
mature miRNAs in the mouse genome and 1048 in the
human genome (miRBase release 16.0, September 2010)
[28] in the mouse and human genomes, respectively.
T h e s ef i g u r e sa r el i k e l yt ob eag r o s su n d e r e s t i m a t eo f
the actual number of miRNAs expressed. Most miRNAs
are short lived, expressed in low abundance and found
in specialised cell types during a specific developmental
stage, and are therefore likely to remain uncharacterised
due to technical limitations or the biological complexity
of the tissues and cells of interest.
The emergence of next-generation sequencing tech-
nologies based on the massively parallel sequencing
(MPS) concept has revolutionised the field of genomics
and transcriptomics [29,30]. High-throughput generation
of sequences from DNA or RNA has enabled the dis-
covery of rare transcripts, such as alternatively spliced
or fusion transcripts, as well as transcripts with low
abundance [31,32]. Many next-generation sequencing
datasets for small RNAs have been generated from the
adult rodent and human brains [33-38]. However, to
date, no small RNA profiling of the developing rodent
or human brain has been performed using these meth-
ods. In this study, we performed deep sequencing of
small RNAs prepared from an E15.5 mouse brain.
In silico and laboratory based analyses led us to the
discovery of 4 putative miRNAs; mm_br_e15_1181,
mm_br_e15_279920, mm_br_e15_96719 and mm_br_
e15_294354. Of these, mm_br_e15_1181 is novel and
potentially involved in mouse embryogenesis, and brain
development and function. This novel miRNA has been
identified as miR-3099.
Results and Discussion
High-throughput sequencing and annotation of small
RNA sequences
A total of 3,763,491 36 nt sequence reads were gener-
ated from a cDNA library constructed from mouse
E15.5 whole brain small RNAs. The dataset was depos-
ited into NCBI Gene Expression Omnibus GSE22653
[39]. Clustering of these sequence reads revealed
413,494 unique tags (Additional file 1). Screening for
adaptor sequences (both 5’ and 3’) using a local blastn
program showed 105,993 unique tags (6.9% or 259,681
sequence reads) did not have adaptor sequences indicat-
ing contamination of larger RNA transcripts during
library construction (Figure 1A). Cloning errors resulted
in 40,622 unique tags (11.0% or 413,837 sequence reads)
consisting of only 5’and 3’ adaptor sequences. The
remaining 266,879 unique tags (82.1% or 3,089,973
sequence reads) were considered legitimate as they con-
tained partial adaptor sequences at 5’ or 3’ or both ends.
Of the legitimate unique tags, 59,710 (6.5% or 245,722
sequence reads) belonged to the 26-29 nt category,
whereas 131,383 unique tags (61.5% or 2,314,244
sequence reads) of 20-25 nt were discovered, and there-
fore formed the majority of the small RNAs found in
the cDNA library (Figure 1B). A total of 48,902 unique
tags (3.8% or 141,783 sequence reads) were classified
into the 16-19 nt category and 26,884 unique tags
(10.3% or 388,224 sequence reads) of 16 nt or shorter
were generated from either a pool of very small RNAs
with unknown function or random RNA degradation
by-products. The recent identification of tiny RNAs
(~17-18 nt) shows that these small RNAs are associated
with transcription initiation and splice sites specific to
metazoans [40,41] suggesting that these tiny RNAs
could be functional and represent another level of regu-
lation during gene transcription in the nucleus.
Bowtie analyses, allowing only perfect matches, were
performed on both the 5’ and 3’ end of each of the
unique tags resulting in 339,201 tags (42% or 1,579,209
sequence reads) not finding a match in the mouse gen-
ome. This large proportion of unmatched unique tags
included adaptors and low quality tags with errors in
sequencing/base-calling. In exceptional circumstances,
these unique tags could be derived from intron/exon or
exon/exon boundaries, fusion transcripts or uncharac-
terised genomic regions. These unique tags with their
corresponding sequence reads were not included for
further analysis. The number of unmatched sequences
varies from one study to another. Morin and colleagues
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from human embryonic stem cells and embryoid bodies
small RNA libraries either consisted of errors or were
not perfectly matched to the human genome [42]. In a
different study, deep sequencing of small RNA libraries
generated from cold-treated and untreated Brachypo-
dium monocot plants resulted in only 49-54% of total
sequence reads matching perfectly to the genome [43].
These studies suggested that a large proportion of the
total sequence reads produced by deep sequencing are
discarded from further analysis due to the quality of the
sequence reads and stringency imposed during sequence
alignment.
A total of 74,293 unique tags (58% or 2,184,282
sequence reads) were perfectly matched to the mouse
genome. Of these, 7,136 (6.2% or 234,381 sequence
reads) were matched to repetitive elements, and 6,929
(0.5% or 17,853 sequence reads) were matched to ‘infra-
structure’ non-coding RNAs such as tRNA, rRNA,
scRNA, snRNA or snoRNA (Table 1; Additional files 2,
3, 4, 5, 6, 7, 8, 9, 10, 11 and 12). These unique tags and
their corresponding sequence reads were also excluded
from further analysis. A total of 45,623 unique tags
(49.6% or 1,867,113 sequence reads) were matched to
either mature miRNA, miRNA star or pre-miRNA from
miRBase, 2,448 (0.1% or 2,775 sequence reads) were
matched to RefSeq, 6,584 (1.3% or 48,465 sequence
reads) were matched to redundant mouse EST
sequences, 1,752 (0.2% or 7,656 sequence reads) mapped
to a single genomic locus and 3,821 (0.2% or 6,039
sequence reads) mapped to multiple loci within the gen-
ome (Figure 1C). Intriguingly, a large number of
mapped unique tags in unique genomic loci have low
abundance and lack association with any known mouse
mRNAs, ESTs or miRNAs suggesting that these small
RNAs could be generated from specific type of cells at
specific stages of development and therefore have not
been characterised to date.
The most abundantly expressed known miRNAs
To assess the expression of known miRNAs in the devel-
oping mouse brain at E15.5, we analysed all 294 mapped
miRNAs in the dataset. Their counts ranged from 1 to
487,654 sequence reads or 0.27 to 129,575 per 1,000,000
sequence reads (CPM). The top 10% of the most abun-
dantly expressed miRNAs are presented in Table 2 (see
full list of known miRNAs in Additional file 13). The most
abundantly expressed miRNA in the E15.5 developing
mouse brain is let-7c-1 with its 7 family members (let-7a-
2, let-7b, let-7d, let-7e, let-7f-2, let-7g and let-7i)h a v i n ga
combined 335,288 CPM. Our finding agrees with the first
report by Lagos-Quintana and colleagues [44] regarding
Figure 1 Generation and analysis of small RNAs sequences. There were 3,763,491 sequence reads generated. (A) Distribution of the small RNA
sequences based on the analysis of 5’ and 3’ adaptor sequences. (B) Distribution of the small RNA sequences based on their size group. (C)
Distribution of the small RNAs according to their annotations. All values presented in the figure were calculated based on the total sequence reads.
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Unique tags
Annotation of unique tags 22 nt of
3’ end*
@
22 nt of
5’ end*
@
Combined
non-redundant^
Total combined
counts^
Additional file(s)
#
Repetitive elements 4,651 3,266 7,136 234,381 2 and 3
’Infrastructure’ non-coding RNAs 6,907 30 6,929 17,853 2 and 3
miRNAs, miRNA stars and pre-miRNAs 45,623 0 45,623 1,867,113 4
RefSeq 2,431 22 2,448 2,775 5 and 6
Redundant mouse ESTs 5,954 737 6,584 48,465 7 and 8
Unique locus in the genome without annotation 1,377 439 1,752 7,656 9 and 10
Multiple loci in the genome without annotation 3,761 241 3,821 6,039 11 and 12
Total 70,704 4,735 74,293 2,184,282
* No mismatch was allowed during Bowtie analysis.
^ Combined non-redundant values.
@ Redundant values are presented. Redundant values were due to the same unique tag being analysed twice in both 5’ and 3’ Bowtie analysis.
# Annotation of unique tags based on 3’ or 5’ end sequences are presented in the additional files 2, 4, 5, 7, 9, 11 and 3, 6, 8, 10, 12, respectively.
Table 2 Top 10% of the most abundantly expressed known miRNAs
Small RNA
ID
Accession
ID
miRNA
ID
Count per
million
Chromosome Start
locus
Stop
locus
Strand
mm_br_e15_1 MI0000559 mmu-let-7c-1 129574.91 16 77599901 77599995 +
mm_br_e15_1010 MI0000563 mmu-let-7f-2 59507.25 X 148346888 148346971 +
mm_br_e15_1001 MI0000557 mmu-let-7a-2 56984.06 9 41344798 41344894 +
mm_br_e15_10749 MI0000721 mmu-mir-9-3 27058.39 7 86650149 86650239 +
mm_br_e15_103211 MI0000137 mmu-let-7 g 25511.42 9 106081170 106081258 +
mm_br_e15_10459 MI0000561 mmu-let-7e 21824.95 17 17967315 17967408 +
mm_br_e15_1036 MI0000558 mmu-let-7b 19422.39 15 85537748 85537833 +
mm_br_e15_10 MI0000588 mmu-mir-103-2 16537.04 2 131113787 131113873 +
mm_br_e15_101787 MI0000138 mmu-let-7i 13005.48 10 122422695 122422780 -
mm_br_e15_10133 MI0000157 mmu-mir-9-2 11269.06 13 83878418 83878490 +
mm_br_e15_106 MI0000720 mmu-mir-9-1 9653.54 3 88019519 88019608 +
mm_br_e15_10266 MI0000405 mmu-let-7d 9457.18 13 48631380 48631483 -
mm_br_e15_10166 MI0000689 mmu-mir-25 7797.55 5 138606548 138606632 -
mm_br_e15_10031 MI0000155 mmu-mir-128-1 7303.33 1 130098937 130099007 +
mm_br_e15_1011 MI0000147 mmu-mir-99b 6712.12 17 17967151 17967221 +
mm_br_e15_10023 MI0000152 mmu-mir-125b-2 5810.83 16 77646517 77646588 +
mm_br_e15_1017 MI0000146 mmu-mir-99a 5567.70 16 77599180 77599245 +
mm_br_e15_13198 MI0000150 mmu-mir-124-3 3957.50 2 180628744 180628812 +
mm_br_e15_10339 MI0000144 mmu-mir-30a 3903.82 1 23279107 23279178 +
mm_br_e15_10279 MI0000165 mmu-mir-140 2629.74 8 110075143 110075213 +
mm_br_e15_1000 MI0005450 mmu-mir-181d 2452.78 8 86702614 86702686 -
mm_br_e15_10303 MI0000697 mmu-mir-181a-1 2322.84 1 139863031 139863118 +
mm_br_e15_11367 MI0000148 mmu-mir-101a 2237.28 4 101019549 101019632 -
mm_br_e15_10306 MI0000704 mmu-mir-320 2137.64 14 70843316 70843398 +
mm_br_e15_10234 MI0000684 mmu-mir-107 2068.03 19 34895176 34895263 -
mm_br_e15_10302 MI0000723 mmu-mir-181b-1 1851.47 1 139863215 139863295 +
mm_br_e15_11023 MI0000549 mmu-mir-30d 1836.86 15 68172769 68172851 -
mm_br_e15_10013 MI0000154 mmu-mir-127 1646.61 12 110831055 110831125 +
mm_br_e15_11551 MI0000729 mmu-mir-7a-2 1597.19 7 86033162 86033259 +
mm_br_e15_100 MI0000719 mmu-mir-92a-1 1563.97 14 115443648 115443728 +
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mouse brain, which was also later found in the primate
brain [45]. Despite their high level of expression in the
brain, the functional role of let-7 in the development of
the central nervous system is poorly characterised. How-
ever, the expression of let-7 has been associated with
neural differentiation and lineage specification processes
in early brain development [46].
Other miRNAs or miRNA families that were abundantly
expressed in the E15.5 developing mouse brain include
miR-124 (3,958 CPM), which promotes and regulates neu-
ronal differentiation [25] and miR-9 (47,981 CPM), which
has a role in the patterning activities and neurogenesis of
the central nervous system [24]. MiR-128 (7,303 CPM)
was highly expressed in our dataset and the finding is in
agreement with a previous study [47]. Down-regulation of
miR-128 expression has been associated with glioblastoma
multiforme [48] whereas its up-regulation has been impli-
cated with reduced neuroblastoma cell motility, invasive-
ness and cell growth [49]. In addition, both miR-128 and
miR-9 are highly expressed in the foetal hippocampus and
differentially regulated in the normal adult hippocampus
as well as the hippocampus of Alzheimer’s disease suf-
ferers [50]. MiR-125 (5,811 CPM) and miR-99 (12,280
CPM) were also expressed highly in the developing mouse
brain. Together with let-7c, both miR-125 and miR-99 are
over-expressed by at least 50% in the foetal hippocampus
of individuals with Down syndrome compared to age and
sex matched controls suggesting that miRNAs are playing
an important role in this brain region, which is pertinent
for learning and long-term memory formation [51]. Inter-
estingly, the miR-103-2 (16,537 CPM), miR-107 (2,068
CPM), miR-181 (6,627 CPM) and miR-30 (5,740 CPM)
families have not previously been associated with the
development of the brain, but were found to be highly
expressed in our dataset. Both miR-103 and miR-107 are
paralogous miRNAs and have been associated with lipid
metabolism [52]. MiR-181 plays a crucial role in modulat-
ing haematopoietic lineage differentiation [53] whereas
miR-30 has been strongly implicated with kidney develop-
ment and nephropathies [54].
The identification of brain-related miRNAs by our
deep sequencing analysis shows that the dataset is reli-
able not only for characterising expression profiles of
known miRNAs but also for discovery of novel miRNAs.
Further investigation of these miRNAs may shed light
on their regulatory roles in various molecular pathways
underlying the development of the embryonic brain.
Screening and validation of putative miRNAs and pre-
miRNAs
To identify putative miRNAs, we analysed unique tags
w i t has i n g l em a t c ht ot h eg e n o m et h a tw e r ea n n o t a t e d
as matched to RefSeq or redundant mouse EST
sequences or were without annotation. A total of 10,784
unique tags (1.6% or 58,896 sequence reads) were
selected under these criteria. We included all sequences
with 1-2 counts into the analysis because we had found
34 known miRNAs residing in a similar range of expres-
sion within the dataset (see Additional File 13), suggest-
ing some of the single count unique tags might be true
positives. Pre-miRNA sequences were predicted using
the RNA22 program, a pattern-based method reported
previously [55]. The program predicted 8 putative miR-
NAs with pre-miRNA sequences; mm_br_e15_1181,
mm_br_e15_279920, mm_br_e15_96719, mm_br_
e15_294354, mm_br_e15_276138, mm_br_e15_331608,
mm_br_e15_255873 and mm_br_e15_363469 (see Addi-
tional File 14). The resulting candidate pre-miRNA
sequences were subjected to hairpin structure or fold
prediction using the RNAfold program [56]. Of all the
candidate putative miRNAs, only 4 fulfilled the criteria
outlined for mature miRNA and pre-miRNA [2]. These
were mm_br_e15_1181 (chr7:6756349-6756370),
mm_br_e15_279920 (chr2:29597247-2959768), mm_br_
e15_96719 (chr7:68982209-68982231), and mm_br_
e15_294354 (chr7:68935407-68935429) which featured a
22-23nt mature miRNAs and a 70-76nt predicted pre-
miRNAs (Figure 2A B and 2D). The other 4 putative
miRNAs, mm_br_e15_276138, mm_br_e15_331608,
mm_br_e15_255873 and mm_br_e15_363469 contained
a large internal loop, branching stem or oversized pre-
miRNA structural properties (see Additional file 14).
T h e s ep u t a t i v em i R N A sw e r ee x c l u d e df r o mf u r t h e r
analysis.
Mm_br_e15_1181 was matched to the second intron of
the ubiquitin specific peptidase 29 (Usp29)g e n e .
Mm_br_e15_279920 was matched to a single locus
within the mouse genome without any annotations,
whereas both mm_br_e15_96719 and mm_br_
e15_294354 miRNAs were matched to two different
introns of the same EST, BU505171. We performed a
small RNA northern analysis on the E15.5 whole brain
small RNAs to validate all the 4 predictions. We also
included mm_br_e15_276138, mm_br_e15_331608,
mm_br_e15_255873 and mm_br_e15_363469 in our
northern analysis to serve as negative controls. The ana-
lysis confirmed all 4 predictions at the mature miRNA
level for mm_br_e15_1181, mm_br_e15_96719 and
mm_br_e15_294354, and at the pre-miRNA level for
mm_br_e15_1181 and mm_br_e15_279920 (Figure 2C).
As expected, the northern analysis of negative controls
showed no detectable signals for mm_br_e15_276138
and mm_br_e15_363469, and multiple bandings for
mm_br_e15_331608 and mm_br_e15_255873, signifying
random by-products due to RNA degradation (see Addi-
tional file 14). Depending on the biological context of
the assessed tissue, miRNA may be preserved or
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Page 5 of 15Figure 2 Validated putative miRNAs. (A) Sequences for both mature miRNA and predicted pre-miRNA. Copy number refers to the occurrences
of the mature sequences in the E15.5 whole brain small RNA sequencing analysis. (B) RNAfold prediction of the stemloop hairpin structure. The
colours in the vertical bar denote the base-pairing probability between two nucleotides within the structure. The black line located next to the
hairpin structure denotes the position of the small RNA within the pre-miRNA. (C) Small RNA northern analysis using radiolabeled
oligonucleotide probes. ‘p’ and ‘m’ refer to pre-miRNA and mature miRNA, respectively. Four independent small RNA northern blots were used
to validate the putative miRNA. After hybridization and washing steps, mm_br_e15_1181 blot was exposed to phosphor screen for 1 day
whereas the other 3 blots for mm_br_e15_279920, mm_br_e15_96719 and mm_br_e15_294354 were exposed for 8 days. (D) Mapping of the
mature miRNA to the mouse genome and other corresponding features such as RefSeq genes, miRNAs from miRBase, mouse ESTs, mammalian
conservation information and repeating elements.
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Page 6 of 15accumulated at the pre-miRNA level due to specific fac-
tors such as the activity levels of dicer, argonaute or
nuclear export receptors [57-59]. Therefore, we consid-
ered the existence of these small RNAs validated when
either the mature or precursor miRNA with specific size
was detected using the northern analysis.
Further analysis using the University of California,
Santa Cruz (UCSC) genome browser [60] showed that
mm_br_e15_1181 was mapped to a region within the
mouse genome that is homologous to the rat and
horse genomes. Other putative miRNAs were mapped
either to a region specific to the mouse genome
(mm_br_e15_294354) or a region homologous to the
rat only (mm_br_e15_279920 and mm_br_e15_96719)
(Figure 2D). By using both the full-length and seed
sequences of all the 4 putative miRNAs, we performed
homology searches against all the known miRNA
sequences and were unable to find any orthologous
miRNAs, indicating that these putative miRNAs could
be specific to the mouse or rat especially
mm_br_e15_1181 and mm_br_e15_96719. Sequence
conservation of miRNAs is relatively common among
vertebrates as well as invertebrates. For example miR-
263 (consisting of miR-263a and miR-263b)a n dmiR-
183 (consisting of miR-96, miR-182 and miR-183)
families are found in many organisms including
human, mouse, chicken, zebrafish, frog, worm and
fruit fly, with high sequence and expression profile
similarity particularly in sensory organs [61,62]. How-
ever, lack of sequence homology among miRNAs from
different organisms does not negate the possibility of
functional conservation among them. For example,
both lin-4 and let-7 target multiple sequence motifs at
the 3’ UTR of Caenorhabditis elegans hunchback
homolog mRNA, hbl-1, and regulate its expression in
the ventral nerve cord neurones [63]. In addition, dif-
ferent miRNAs with similarity at the seed region may
exert the same effect on a same mRNA. Drosophila
bearded (Brd) gene has motifs that are complementary
to two different miRNAs, miR-4 and miR-79,w h i c h
bear the same seed sequence. Both the miRNAs target
the motifs based entirely on the seed sequence with
little or no base-pairing to the 3’ region [64].
Although this phenomenon is rare across different
organisms, it proves that functional conservation
between non-conserved miRNAs may lie within the
seed region alone.
Mm_br_e15_1181 biogenesis is Dicer1-dependent
Of the 4 putative miRNAs, we selected
mm_br_e15_1181 for further characterisation due to
its high copy number. First, we evaluated
mm_br_e15_1181 expression in mouse embryonic
stem (mES) cells, with and without Dicer1 enzyme
activity using the stemloop RT-qPCR technique
(Figure 3A). Mm_br_e15_1181 was expressed in mES
cells with Dicer1 activity, however its expression was
not detected or was weak in cells lacking Dicer1 activ-
ity confirming that mm_br_e15_1181 biogenesis is
Dicer1-dependent (P < 0.01). The evaluation of Dicer1-
dependency using the mES cell model is limited to
miRNAs that are expressed in this cell type. It is worth
noting that Dicer1-dependency is not a definitive prop-
erty for defining mm_br_e15_1181 as a novel miRNA
because endogenous small siRNAs are also subjected
to the same dicing mechanism in the cytoplasm [1]. A
recent study reported the Dicer1-independent biogen-
esis of miR-451, in which the catalytic activity of Argo-
naute2 was responsible for the pre-mir-451 hairpin
cleavage process [65].
In this study, we used a number of validation analyses
for mm_br_e15_1181: Dicer1-dependence, pre-miRNA
structure prediction and northern analysis to define
m m _ b r _ e 1 5 _ 1 1 8 1a san o v e lm i R N A .T h i sn o v e l
miRNA has been identified as miR-3099.
Expression profiling of miR-3099 throughout
embryogenesis
The expression of miR-3099 in mES cells led us to
h y p o t h e s i z et h a tt h i sm i R N Am a yp l a yar o l ei ne a r l y
embryogenesis and therefore we characterised its
expression profile throughout development. Using stem-
loop RT-qPCR, we showed that miR-3099 was expressed
in E3.5 blastocysts (Figure 3B). The expression of miR-
3099 reduced (by ~9-fold; P <0 . 0 0 1 )a st h eb l a s t o c y s t s
developed into an early stage embryo at day 7 (E7), sug-
gesting that miR-3099 was either expressed in a spatially
restricted manner or generally down-regulated at this
stage. To specifically locate the expression of miR-3099
during embryogenesis, we performed whole mount in
situ hybridisation on E9.5 embryos (n = 3) and showed
that miR-3099 was expressed throughout the embryo
with the exception of the developing heart (Figure 3C).
Stronger expression was observed in the telencephalon,
somites, branchial arches, and both forelimb and hin-
dlimb buds. Cross sectional analysis of the telencephalon
confirmed that miR-3099 was expressed in the neuroe-
pithelium (Figure 3D). Whole mount ISH analysis on
embryos of the same age was performed using miR-
scrambled LNA probe to serve as the background con-
trol (n = 2) (Figure 3E &3F).
To evaluate the expression profile of miR-3099 in the
later stages of embryogenesis, we performed section
ISH. Section ISH of the E11.5 whole embryos showed
that miR-3099 was expressed throughout the embryo,
especially in the preplate of the telencephalon, somites
and hindlimb region (Figure 4). By E13.5, miR-3099
expression was restricted to the cortical plate of
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Page 7 of 15the cortical neuroepithelium, striatum, medial pallium
(hippocampal allocortex) and subventricular/ventricu-
lar zone of the superior and inferior colliculi. In E15.5
embryos, miR-3099 expression was observed primarily
in the cortical plate of the cerebral cortex. In E17.5
whole brains, miR-3099 expression was prominent in
the cortical plate, piriform cortex and at lower levels,
in the hippocampal formation. Embryo-wide expression
of miR-3099 during early embryogenesis suggests a
pan-regulatory role, possibly functioning as a ‘house-
keeping’ miRNA in basic cellular processes. This fea-
ture has been described in a few clusters of miRNAs
expressed in the mouse retina, brain and heart [66].
Many miRNAs have ubiquitous expression patterns
and their function remains unclear as they may have
roles in subtle miRNA networks, which exert combina-
torial effects during development [67,68]. Contrasting
with the almost ubiquitous expression profile in early
development, miR-3099 was not detected in a few
r e g i o n ss u c ha st h eE 9 . 5d e v e l o p i n gh e a r ta n dt h ev e n -
tricular zone of the telencephalon/developing cere-
brum. This suggests that the function of miR-3099
may be tissue or cell-specific, especially after E11.5,
this warrants further characterisation.
We also performed stemloop RT-qPCR expression
analysis of miR-3099 in various regions of the mouse
brain and organs. Using the mouse whole brain, there
was a significant difference (P = 0.02) in the miR-3099
expression among E11.5, E13.5, E15.5, E17.5, postnatal
day (P) 1.5 and P150 samples (Figure 5A). MiR-3099
expression was found to be increased after E11.5 and
was maintained in postnatal day 1.5 (P1.5) and P150
whole brains. The qPCR analysis supports the previous
section ISH analysis. No significant differences (P =
0.45) in miR-3099 expression were observed among cer-
ebellum, cerebrum, hippocampus, medulla, olfactory
bulb and thalamus (Figure 5B). When we compared the
expression of miR-3099 in various adult mouse organs
t ot h eP 1 5 0w h o l eb r a i n ,w ef o u n ds i g n i f i c a n td i f f e r -
ences in the expression levels among the organs (P <
0.001) (Figure 5C). MiR-3099 was found to be expressed
at the highest level in the pancreas, followed by the thy-
mus, large intestine, heart, small intestine, kidney, brain,
testis, ovary, skin, skeletal muscle, liver, stomach and
spleen. Similar to the embryonic expression profiles, the
diverse expression profile of miR-3099 in multiple
organs of the adult mouse further supports a widespread
role in the development and function of these organs.
Figure 3 Expression profiling of miR-3099 novel miRNA in mouse embryonic stem cells (with conditional allele for Dicer), E3.5 blastocysts,
E7 and E9.5 embryos. (A) Stemloop RT-qPCR analysis of miR-3099 novel miRNA in mouse embryonic stem (mES) cells with conditional allele for
Dicer1. mES cells with and without Dicer1 activity are denoted by Dicer c/- and Dicer -/-, respectively (n = 3 per group). (B) Expression of miR-3099 in
E3.5 blastocysts (n = 14; pooled) and the E7 whole embryo (n = 3). (C-F) Whole mount ISH of E9.5 embryos using DIG-labeled LNA probes for miR-
3099 (C and D) (n = 3) and miR-scrambled (E and F) (n = 2). Cryosection of the stained embryos shows expression of miR-3099 in the neuroepithelium
of the telencephalon (D, inset in C). BA = branchial arches, DH = developing heart, FLB = forelimb bud, HLB = hindlimb bud, Mes = mesencephalon,
NE = neuroepithelium, SO = somite, Tel = telencephalon. The mean ± SE for each tissue is presented in the bar graphs. Asterisks denote the statistical
significance level at P < 0.01 (**) and P < 0.001 (***) based on the one-way ANOVA test (see Additional file 14 for analysis details).
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Page 8 of 15Figure 4 Expression profiling of miR-3099 novel miRNA in E11.5-E15.5 whole embryos and the E17.5 whole brain. In situ
hybridisation analysis using LNA probes for miR-scrambled and miR-3099 was performed on E11.5-E15.5 developing embryos and E17.5
whole brain paraffin sections. Strong expression of miR-3099 was detected in the E11.5 embryo. From E13.5 onwards, the expression was
retained only in the neuroepithelium (NE) or cerebral cortex (CC). Under high magnification, miR-3099 was found to express specifically in
the preplate (PP) of telencephalon (tel) (E11.5), cortical plate (CP) of the CC (E13.5-E17.5) and the germinal layer of mesencephalon (mes)
(E11.5-E13.5). Aq = aqueduct, CB = cerebellum, Cp = caudo-putamen, dien = diencephalon, Hpf = hippocampal formation, IC = inferior
colliculus, IZ = intermediate zone, LV = lateral ventricle, met = metencephalon, Mo = molecular layer, MPall = medial pallium (hippocampal
allocortex), MZ = marginal zone, PIR = piriform cortex, SC = superior colliculus, SP = subplate, Str = striatum, SVZ = subventricular zone,
V = ventricle.
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Page 9 of 15Expression of miR-3099 is upregulated in differentiating
neuronal/glial cells
Expression of miR-3099 was observed in the preplate of
the E11.5 telencephalon and later in the cortical plate of
the E13.5-E17.5 cerebral cortex, by which time the
majority of the cells in these structures are committed
to their respective neuronal lineages. This finding
further suggests that miR-3099 may play an important
regulatory role during neurogenesis or in neuronal func-
tion. To further test this idea, we used P19 teratocarci-
noma cells as an in vitro model. Upon retinoic acid
induction and under reduced serum concentration, P19
cells differentiate into glutamatergic and glutamate-
responsive neurones, glial and fibroblast-like cells
[69-72]. We analysed the expression level of miR-3099
in P19 cells (Figure 6A) and found a statistically signifi-
cant (P = 0.04) ~2-fold upregulation of miR-3099 in
~50% differentiated P19 cells compared to the prolifer-
ating cells (Figure 6B). Various miRNAs have been
found to be upregulated during neural differentiation
and some of their expression could be negatively regu-
lated by important transcription factors such as Oct4
and Sox2, the expression levels of which gradually
diminish as cells differentiate into neurones [73]. There-
fore, increased miR-3099 expression during P19 differ-
entiation raises the possibility that this miRNA may
Figure 6 Expression of miR-3099 in P19 teratocarcinoma cells.
(A) Phase contrast micrographs of differentiating and proliferating
P19 cells. (B) Stemloop RT-qPCR analysis of miR-3099 expression in
differentiating (diff.) (n = 3) and proliferating (prolif.) (n = 2) P19
cells. The mean ± SE for each cell type is presented in the bar
graph. The asterisk (*) denotes statistical significance at P < 0.05
based on the one-way ANOVA test (see Additional file 14 for
analysis details).
Figure 5 Expression profiling of miR-3099 novel miRNA in the
whole brain of different developmental stages, different adult
mouse brain regions and organs. Stemloop RT-qPCR analysis of miR-
3099 in E11.5-P150 whole brain (A), brain regions in P150 whole brain
(B) (n = 2 for each group) and various mouse organs harvested from
P150 adult mouse (C) (n = 2 for all except P150 whole brain, skeletal
muscle, spleen, stomach and testes, where n = 3). The mean ± SE for
each organ is presented in the bar graphs. The one-way ANOVA test is
significant at P < 0.05 for (A), not significant for (B) and P < 0.001 for
(C) (see Additional file 14 for analysis details).
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Page 10 of 15have a functional role during neural differentiation or
neuronal cell function.
Conclusions
In this study, we have reported the first deep sequencing
analysis of small RNAs of a developing mouse brain. We
have identified and validated 4 putative miRNAs from
the analysis and further characterised one of them, miR-
3099, during embryogenesis. A significant finding of the
study was the embryo-wide expression profile of miR-
3099 in mid-gestation embryos, which became restricted
to the central nervous system, suggesting a role for this
miRNA in neural differentiation or function.
Methods
Animals and dissections
The Melbourne Health Animal Ethics Committee and
the University of Adelaide Animal Ethics Committee
approved procedures involved in the breeding and hand-
ling of animals. Mice were housed under a 12-hour light
and 12-hour dark cycle with access to unlimited food
and water. Mice were culled by CO2 inhalation and all
dissections of mouse embryos, brains and organs were
carried out according to the methods described pre-
viously [18].
Deep sequencing and analysis
Total RNA was isolated from a whole brain dissected
from an E15.5 embryo of C57BL/6 background using
TRIzol reagent (Invitrogen) according to the manufac-
turer’s protocol. Small RNAs with sizes ranging from
16-30nt were isolated from 10 μg total RNA using poly-
acrylamide gel electrophoresis. The complementary
small RNA library was constructed using the Small
RNA Sample Prep Kit version 1.0 (Illumina) according
to the manufacturer’sp r o t o c o lw i t h5 ’-GTTCAGAGTT
CTACAGTCCG ACGATC-3’ and 5’-TCGTATGCCG
TCTTCTGCTT GT-3’ adapters at the 5’ and 3’ ends,
respectively. Sequencing was carried out using a Gen-
ome Analyzer II (Illumina). Image data was generated
by the Genome Analyzer II and was processed using the
Illumina pipeline software (Pipeline version 1.0 was used
for the FASTQ data). This consists of an image analysis
module (Firecrest), followed by basecalling using the
BUSTARD module and finally production of a data file
in FASTQ format using the GERALD module.
Sequence annotation pipeline
The FASTQ data was ranked according to decreasing
abundance of the unique tags. This file was created
using a PERL script in Linux without taking into consid-
eration any filters (adapter sequences) or quality. A file
with unique tags and their corresponding counts was
generated. All unique tags (including those with a single
count) were mapped to the NCBI Mouse Assembly
Build 37.1 using the Bowtie program [74]. Two sets of
alignments were carried out: one stripping off 14 bases
from the 5’ end of unique tags and the other stripping
off 14 bases from the 3’ end. In both alignments, no
mismatches are allowed and unique tags that hit more
than one locus within the mouse genome were dis-
carded. Unique tags with a single hit within the genome
were further annotated using various databases such as
RepeatMasker (analysis was performed on NCBI Mouse
Assembly build 37.1 and the output was downloaded
from UCSC genome browser on the 28
th of November,
2008), mouse RefSeq in release 32, mouse miRNA in
miRBase release 12.0 and redundant mouse EST data-
base (downloaded from UCSC mm9 on 27
th January,
2009).
Identification of candidate novel miRNAs
Unique tags that mapped to a genomic locus with a
RefSeq, redundant EST or no annotations were sub-
jected to pre-miRNA prediction using the RNA22 pro-
gram [55]. Sequences encompassing 100- to 200-nt
upstream and downstream of these unique sequences
were used to predict any potential pre-miRNAs with
hairpin structures. The minimum number of patterns
that should support a pre-miRNA before it can get
reported was set to 60, and the minimum and maximum
pre-miRNA lengths were set to 60nt and 150nt, respec-
tively. All predicted pre-miRNA sequences based on
these settings were used to determine the hairpin fold
structure using RNAfold program [56]. The predicted
hairpin fold structure with the lowest minimum free
energy (MFE) (cut off at -30 kcal/mol or lower) and
conforming to the annotation criteria for pre-miRNA
[2] was selected as the final predicted pre-miRNA.
Briefly, the predicted precursor structure must be
between 60-80 nt in size and must not have a large
internal loop or any asymmetric bulges. The predicted
pre-miRNA must contain the aligned unique sequence
within one arm of the hairpin and include at least 16 bp
from the 5’ end of the unique sequence and the other
arm of the hairpin.
Small RNA northern analysis
Eight blots were prepared from four independent E15.5
whole brains. Approximately 30 μgo ft o t a lR N Aw a s
denatured in 1X Ambion Gel Loading Buffer II
(Ambion
®) at 85°C for 3 minutes. RNAs were electro-
phoresed in 15% acrylamide/urea gels (48% (w/v) urea,
15% (v/v) acrylamide, 0.05% (w/v) ammonium persulfate
and 0.1% (v/v) tetramethylethylenediamine prepared in
1X TBE) in 1X TBE buffer at 300 V for 90 minutes.
Separated small RNAs in the gel were then transferred
onto Hybond-N+ nylon membrane (GE Healthcare)
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® SD Semi-Dry Electrophoretic Trans-
fer Cell (Bio-Rad) at a constant 0.4 V for 45 minutes.
The pre-hybridisation step was carried out in Amersham
Rapid-hyb™ Buffer (GE Healthcare) with 100 μg/ml of
herring sperm DNA (Promega) at 42°C for 1 hour and
was followed by the hybridisation step. The same pre-
hybridisation solution was used for hybridisation with
addition of 2 × 10
6 dpm/ml labelled probe prepared
using 20 U of T4 Polynucleotide Kinase (Promega) in
1X kinase buffer (Promega) and 50 pmol of [g-
32P]-
dATP (GE Healthcare) (3000 Ci/mmol). Hybridisation
was carried out for 18 hours and filters were washed in
5 × SSC with 0.1% (w/v) sodium dodecyl sulfate (SDS)
(20 minutes at 37°C) followed by 1 × SSC with 0.1% (w/
v) SDS and 0.2 × SSC with 0.1% (w/v) SDS (15 minutes
each time at 65°C until a clean background signal was
obtained). The membrane was exposed to a storage
phosphor screen in a cassette at room temperature for 1
day for miR-3099 blot and 8 days for other blots before
scanned using Typhoon™ 9400 (GE Healthcare).
Stemloop RT-qPCR
Reverse transcription of the small RNA was performed
based on modified methods [75,76]. cDNA was synthe-
sised from 150 ng-2.5 μg of small RNA enriched total
RNA using 0.05 μM of an in-house designed stem loop
primer (5’-GTTGGCTCT GGTAGGATG CCGCTC
TCA GGGCATCCT ACCAGAGCCA AACTCCCCA-3’,
GeneWorks), and the Superscript
® III Reverse Tran-
scriptase Kit (Invitrogen) with modifications to the man-
ufacturer’s protocol. The stem loop primer was added
after a denaturation step at 65°C for 5 minutes. The last
6 n ta tt h e3 ’ end of the stem loop primer complements
the last 6nt of the 3’ end of miR-3099 small RNA. The
stem loop RT primer contains a target site for a univer-
sal reverse primer (5’-GTAGGATGCC GCTCTCAGG-
3’, GeneWorks) and a target site for UniversalProbe
Library (UPL) Probe #21 (Roche Diagnostics), which
were used in subsequent cDNA amplification processes
together with a specific forward primer for miR-3099
(5’-CGCGTAGGCT AGAGAGAGGT-3’, GeneWorks).
Briefly, cDNA synthesis was performed at 16°C for 30
minutes followed by 60 cycles of 20°C for 30 seconds,
42°C for 30 seconds and 50°C for 1 second. A final incu-
bation at 75°C for 15 minutes was performed to inacti-
vate the reverse transcriptase enzyme.
Prior to qPCR, pre-PCR of miR-3099 was performed
in a 10 μl reaction volume containing 1X LC480 Probe
Master mix (Roche Diagnostics), 50 nM of each forward
and universal reverse primers and 0.2X of synthesised
cDNA. Pre-PCR was initially carried out at 95°C for
10 minutes, 55°C for 2 minutes and 75°C for 2 minutes
and followed by 14 additional cycles of 95°C for
15 seconds and 60°C for 4 minutes. After pre-PCR,
0.01X of amplicons were used for qPCR.
QPCR was carried out in 10 μl reaction volume using
1X LightCycler 480 (LC480) Probe Master mix (Roche
Diagnostics), 0.1 μM of a relevant Universal ProbeLi-
brary probe (Roche Diagnostics), 0.25 μMo fe a c hf o r -
ward and reverse primers and 1 μlo f0 . 1 Xo f
synthesised cDNA. Reactions were prepared in 384-well
plates and RT-qPCR was performed using a LightCy-
cler
® 480 Real Time PCR System instrument (Roche
Diagnostics). QPCR was performed with an initial dena-
turation at 95°C for 10 minutes followed by 45 cycles at
95°C for 10 seconds, 60°C for 30 seconds and 72°C for
10 seconds, and a final step at 40°C for 1 second.
Real-Time amplification signals were acquired during
the elongation step and recorded live using LightCycler
®
480 Software version 1.5 (Roche Diagnostics). The cycle
threshold or crossing point (Cp) from each signal was
calculated based on the Second Derivative Maximum
method [77]. A 4-data point standard curve was con-
structed using serially diluted pooled cDNAs for each
primer set used in qPCR in each run. The standard
curve was used to determine the PCR efficiency and
reproducibility of each PCR system. The Hmbs gene was
used as reference gene normalisation according to the
method as described [18].
Statistical analysis
Two or three independent biological replicates were
used for each tissue/organ in each experiment. Two
qPCR experiments were performed on the tissue of each
biological replicate. The qPCR results were normalized
to Hmbs, and those that were not outliers, log2 trans-
formed and then averaged to give the expression data
for the biological replicate. One-way ANOVA was used
to compare the expression levels among the tissues.
A P value of <0.05 was considered statistically signifi-
cant. Where significant differences were detected among
the tissues the least significant difference(s) (LSD) were
provided with the analysis (see Additional file 14 for
analysis details).
Locked Nucleic Acids - In situ hybridisation
Paraffin embedded sections (8 μm) were used for LNA-
ISH. Sections were de-paraffinised with washes in xylene
(3× for 5 minutes each) and hydrated in a series of etha-
nol concentrations into RNase-free water. Subsequently,
sections were fixed in 4% (w/v) PFA (pH7.0) in 1X PBS
(10 minutes) followed by Proteinase K digestion (6.7 μg/
ml of Proteinase K, 50 mM of Tris HCl pH7.5, 5 mM of
EDTA) for 30 minutes, re-fixed in 4% (w/v) PFA in 1X
PBS for 5 minutes and acetylated (0.1 M of triethanola-
mine, 0.178% (v/v) of concentrated HCl and 0.25% (v/v)
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sections were washed multiple times using 1X PBS.
The pre-hybridisation step was carried out in a humi-
dified chamber (50% (v/v) formamide, 5X sodium chlor-
ide/sodium citrate, SSC) at 60°C. Amersham Rapid-
hyb™ Buffer (GE Healthcare) was used for pre-hybridi-
sation with additional Escherichia coli tRNA (Sigma
Aldrich) and Herring Sperm DNA (Promega) to a final
concentration of 100 μg/ml each. After 1-2 hours of
pre-hybridisation, custom-made Sox4_sir3 LNA probes
(Cat. no: EQ-70537, Exiqon) were added to the buffer to
give a concentration of 0.020 pmol/μl. Hybridisation was
carried out in the oven for 16-20 hours.
After the hybridisation step, sections were washed in 5
× SSC (20 minutes at hybridisation temperature) fol-
lowed by 0.2 × SSC (3 hours at hybridisation tempera-
ture). Sections were then rinsed in fresh 0.2 × SSC for 5
minutes and in pre-blocking buffer (0.1 M of Tris HCl
pH7.5, 0.15 M of NaCl and 240 μg/ml of levamisole) for
a further 5 minutes. In a humidified chamber, sections
were blocked in 20% (v/v) foetal calf serum (Sigma
Aldrich) and 2% (w/v) blocking powder (Roche Diagnos-
tics) in maleate buffer for 1 hour. After blocking, sec-
tions were incubated with 0.0002X (0.00015 U) anti-
DIG antibody with alkaline phosphatase, Fab fragments
(Roche Diagnostics) in blocking buffer for 16 hours in
the dark. Subsequently, sections were washed in NTMT
buffer (3× for 10 minutes each: 0.1 M Tris HCl pH9.5,
0.1 M NaCl, 0.05 M MgCl2, 1% (v/v) Tween-20 and 240
μg/ml levamisole) and then with nitro blue tetrazolium
chloride (NBT)/5-Bromo-4-chloro-3-indolyl phosphate,
toluidine salt (BCIP) colour reaction (0.375 mg/ml of
NBT and 0.188 mg/ml of BCIP in NTMT buffer) for
3 hours to 5 days. After the colour reaction step,
sections were washed with Tris EDTA buffer pH8.0
(0.01 M of Tris HCl pH7.5 and 0.001 M EDTA pH8.0)
for 10 minutes and were mounted in Entellan
® media
(ProSciTech).
P19 teratocarcinoma cells
Propagation and differentiation of P19 cells were carried
out according to protocols previously described [18,78].
Mouse embryonic stem (mES) cells with Dicer1
c
conditional allele
Mouse embryonic stem (mES) cells with Dicer1 activity
were of a line heterozygous for a conditionally mutant
Dicer1 allele (Dicer1
c) and a null Dicer1 allele (Dicer1
-),
these genetic modifications have been previously
described [79]. mES cells without Dicer1 activity were
produced by transient transfection of this Dicer1
c/- line
with Cre recombinase to produce Dicer1
-/- subclones
(JRM and DMM, unpublished data). The mES cells were
propagated as previously described [80].
Mouse E3.5 blastocysts
C57BL/6 females of 3-4 weeks of age were superovu-
lated using 5IU of Folligon (PMSG) followed by 5IU of
Chorulon (HCG) 47.5 hours later and mated with
B6D2F1 entire stud males. Microdrop culture dishes
were set up to equilibrate in 37°C, 5% CO2 incubator
4 hours prior to culture. KSOM (Millipore) media was
used in 20 μl droplets in a 35 mm dish, overlaid with
Embryo Tested Mineral Oil (Sigma). Superovulated
female mice were sacrificed after 2.5 days of superovula-
tion induction and mating, and oviducts were collected
into M2 handling media (Millipore). Oviducts were
flushed using M2 media, a blunt 30G needle and a1ml
syringe. Morulae were collected and cultured in pre-
equilibrated KSOM. Blastocysts were collected from cul-
ture a day later under a dissecting microscope. These
were considered E3.5 blastocysts.
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